Panther Biotechnology Announces New Drug Candidate to Selectively Kill … – Marketwired (press release)
|
Panther Biotechnology Announces New Drug Candidate to Selectively Kill …
Marketwired (press release) The licensed compound, called TDZD-8, is a small molecule engineered to kill leukemic stem cells. TDZD-8 has demonstrated broad and selective in vitro activity against many different types of leukemia. In addition, TDZD-8 has no significant toxicity in … |
